MY ABPI LOGIN
 
Tags - Opinion

It’s never been more important to tell the great story of vaccines, says ABPI Chief Executive, Richard Torbett

ABPI Chief Executive talks about the importance of vaccines, as ABPI launches its new campaign, #ValuingVaccines. 

UK steps up its role in fighting global AMR

With 10 million people a year projected to die from antibiotic-resistant infections by 2050, it’s important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue.

Research must be for everyone, says ABPI President

In its second annual clinical trials report launched this week, the ABPI is calling for the research community to work with Government, funders, and the public to tackle issues around diversity and inclusion in research. This is essential, says ABPI President Haseeb Ahmad.

The taskforce for lung health shows that collaboration gets results

The Taskforce for Lung Health has been awarded Charity Collaboration of the Year at the Charity Times awards. Su Jones, NHS Engagement Partner at the ABPI and Dr Alison Cook, Chair of the Taskforce for Lung Health, explain the importance of the Taskforce and look to the future of its work.  

Gavi: Partnering to protect future generations from infectious diseases

As Gavi marks its twentieth anniversary, a new report from the ABPI and IFPMA looks at the past successes of the Vaccines Alliance and what the future holds.

International Clinical Trials Day - how is COVID-19 affecting research?

On International Clinical Trials Day, Dr Sheuli Porkess considers the impact that COVID-19 is having on clinical trials and the potential lessons for the future research.

What new data tells us about Academia-Industry links

Malcolm Skingle CBE PhD, Chair of the ABPI's ACES Strategic Leadership Group, looks at the data from our most recent survey of academic-industry links.

Repurposing – what is it and why it’s important for COVID-19

COVID-19 has emerged as a brand new disease with a severe impact on patients, the public and health systems around the world. 

Levelling up the country means playing to our strengths

The balance the Chancellor needs to strike in delivering his first Budget on Wednesday has been made even tougher by the need to prioritise measures to tackle coronavirus.

Rare diseases and clinical research: How can we maximise the chances of success?

Our President Haseeb Ahmad sets out how industry is working to find treatments and cures for some of the world’s most complex diseases. Nowhere is the need to find new medicines more acute than in rare diseases, many of which are genetic and affect the youngest patients.  

A patient population of 3.5million people can’t be ignored

We spoke to Dr Lucy McKay, CEO of the charity Medics4RareDiseases. She told us why health professionals should ‘dare to think rare’ in their patients.
;